ORIC Pharmaceuticals upgraded by Goldman with a new price target

Historical context for ORIC

Across the 25 sessions after earlier ORIC headlines, the stock closed higher 11 times and lower 12 times, with a median move of 2.3% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.

Keep researching ORIC

• What is Analyst upgrade?A sell-side analyst's move to a more favorable rating on a stock, such as from Hold to Buy, usually published with a new price target and thesis.
• Analyst upgrades and downgradesAn analyst upgrade or downgrade is a change in a sell-side analyst's stock rating. Learn what Buy, Hold and Sell mean, how price targets work and which changes matter.
• ORIC insider tradesEvery buy and sale reported by Oric Pharmaceuticals Inc. officers, directors and large holders.
• ORIC earnings historyPast Oric Pharmaceuticals Inc. earnings releases, newest first.
• ORIC financial statementsRevenue, profit, cash flow and balance sheet from Oric Pharmaceuticals Inc.'s SEC filings.